Effectdossier · gearchiveerd kwartaal
RXRX
Recursion Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Gevolgde houders
-2Δ houders
173.92MGehouden aandelen
$848.75MGerapporteerde waarde
+0Nieuwe posities
−3Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -11.1% ·
aandelenstroom +8.8% ·
netto nieuwe posities -18.8%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | -2 | 264.97M | $972.27M | +5 | −6 |
| Q1 2026 | 107 | +3 | 243.54M | $747.81M | +9 | −7 |
| Q4 2025 | 104 | +2 | 261.79M | $1.07B | +4 | −1 |
| Q3 2025 | 16 | -2 | 173.92M | $848.75M | — | −3 |
| Q2 2025 | 16 | 0 | 153.65M | $777.46M | — | — |
| Q1 2025 | 13 | +3 | 87.35M | $462.12M | +3 | — |
| Q4 2024 | 10 | 0 | 84.02M | $567.97M | — | — |
| Q3 2024 | 9 | +2 | 69.10M | $455.38M | +2 | — |
| Q2 2024 | 7 | — | 63.72M | $477.87M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 39.78M | +10.3% | $194.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 39.78M | +10.3% | $194.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 39.78M | +10.3% | $194.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 39.78M | +10.3% | $194.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 39.78M | +10.3% | $194.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | ARK Investment Management ✦ | 33.55M | +1.7% | $163.70M | 1.0% | ▲ Add | 6 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 31.74M | +11.9% | $154.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 23.98M | -0.8% | $117.02M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 23.98M | -0.8% | $117.02M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 23.98M | -0.8% | $117.02M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 23.98M | -0.8% | $117.02M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (passief) | 18.27M | +63.4% | $89.15M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passief) | 9.62M | +23.8% | $46.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 9.62M | +23.8% | $46.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 7.29M | — | $35.58M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 3.23M | -42.2% | $15.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 3.23M | -42.2% | $15.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 3.23M | -42.2% | $15.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 40 | Two Sigma Investments ✦ | 2.45M | +109.9% | $11.96M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 1.35M | +2.6% | $6.58M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 1.35M | +2.6% | $6.58M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | Goldman Sachs Group ✦ | 1.26M | — | $6.16M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Goldman Sachs Group ✦ | 1.26M | — | $6.16M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 1.26M | — | $6.16M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | JPMorgan Chase ✦ | 839.24K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | T. Rowe Price ✦ | 318.88K | +13.2% | $1.56M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 59 | Wellington Management ✦ | 153.28K | +61.4% | $747,991 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 60 | Wellington Management ✦ | 153.28K | +61.4% | $747,991 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 61 | Wellington Management ✦ | 153.28K | +61.4% | $747,991 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 62 | Wellington Management ✦ | 153.28K | +61.4% | $747,991 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 63 | Marshall Wace ✦ | 78.26K | -9.3% | $381,903 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 64 | Marshall Wace ✦ | 78.26K | -9.3% | $381,903 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 65 | AQR Capital Management ✦ | 14.91K | +7.3% | $72,761 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 66 | AQR Capital Management ✦ | 14.91K | +7.3% | $72,761 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 67 | AQR Capital Management ✦ | 14.91K | +7.3% | $72,761 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 68 | AQR Capital Management ✦ | 14.91K | +7.3% | $72,761 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $16.04M | was 0.0% |
| Millennium Management | $3.74M | was 0.0% |
| D. E. Shaw & Co. | $3.21M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 333 houders, 334.81M aandelen, $1.02B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Aug 07
SC 13G — STATE STREET CORP
Jul 31
SC 13G — VANGUARD PORTFOLIO MANAGEMENT LLC
Jul 31
SC 13G — VANGUARD CAPITAL MANAGEMENT LLC
Jul 29
SC 13G/A — BlackRock, Inc.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API